US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Rwe AG Neu Essen (PK) (RWNFF) 銘柄情報

Rwe AG Neu Essen (PK) (RWNFF)

64.61

1.79

(2.85%)

終了 7月3日 5:00AM

Rwe AG Neu Essen (PK) (RWNFF) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

64.61

( 2.85% )

買値

62.95

売値

66.34

出来高

1,994

64.06 日の範囲 65.43

39.07 52 週間の範囲 73.86

時価総額

前日終値

62.818

始値

65.328

時刻

最終取引時間

財務取引量

US$ 129,350

VWAP

64.8694

平均取引量 (3 か月)

US$ 1,831,822

発行済株式数

707,031,331

配当利回り

1.2 (2.11%)

PER

16.52

1 株当たり利益 (EPS)

3.27

歳入

16.27B

純利益

2.36B

RWE Aktiengesellschaft generates and supplies electricity from renewable and conventional sources in Germany, the United Kingdom, rest of Europe, North America, and internationally. It operates through five segments: Offshore Wind; Onshore Wind/Solar; Flexible Generation; Supply & Trading; and Phase... RWE Aktiengesellschaft generates and supplies electricity from renewable and conventional sources in Germany, the United Kingdom, rest of Europe, North America, and internationally. It operates through five segments: Offshore Wind; Onshore Wind/Solar; Flexible Generation; Supply & Trading; and Phaseout Technologies. The company generates wind, hydro, solar, gas, lignite, and biomass electricity. It also trades in electricity, gas, and energy commodities; operates gas storage facilities; and engages in battery storage activities, as well as lignite mining and refining. The company serves commercial, industrial, and municipal customers. RWE Aktiengesellschaft was founded in 1898 and is headquartered in Essen, Germany. 詳細を表示

セクター

Utilities

業界

Regulated Utilities

ウェブサイト

www.rwe.com

本社

Essen, Germany

設立

1898

Rwe AG Neu Essen (PK) is listed in the Utilities sector of the その他OTC with ticker RWNFF. The last closing price for Rwe AG Neu Essen (PK) was US$62.82. Over the last year, Rwe AG Neu Essen (PK) shares have traded in a share price range of US$ 39.07 to US$ 73.86.

Rwe AG Neu Essen (PK) currently has 707,031,331 shares in issue. The market capitalisation of Rwe AG Neu Essen (PK) is US$45.68 billion. Rwe AG Neu Essen (PK) has a price to earnings ratio (PE ratio) of 16.52.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	1.484	2.35085384786	63.126	65.43	61.004	1686	63.03129632	CS
4	0.584	0.912129447412	64.026	67.502	61.004	3984	64.67359288	CS
12	-4.712	-6.79726493754	69.322	73.86	61.004	3769	66.67561701	CS
26	9.098	16.3892491714	55.512	73.86	54.062	4024	64.50051359	CS
52	23.9	58.7079341685	40.71	73.86	39.07	23479	45.44433996	CS
156	21.438	49.6571852126	43.172	73.86	28.72	14312	45.05723727	CS
260	27.86	75.8095238095	36.75	73.86	28.72	11291	44.78308192	CS

RWNFF - Frequently Asked Questions (FAQ)

What is the current Rwe AG Neu Essen (PK) share price?

The current share price of Rwe AG Neu Essen (PK) is US$ 64.61

How many Rwe AG Neu Essen (PK) shares are in issue?

Rwe AG Neu Essen (PK) has 707,031,331 shares in issue

What is the market cap of Rwe AG Neu Essen (PK)?

The market capitalisation of Rwe AG Neu Essen (PK) is USD 45.68B

What is the 1 year trading range for Rwe AG Neu Essen (PK) share price?

Rwe AG Neu Essen (PK) has traded in the range of US$ 39.07 to US$ 73.86 during the past year

What is the PE ratio of Rwe AG Neu Essen (PK)?

The price to earnings ratio of Rwe AG Neu Essen (PK) is 16.52

What is the cash to sales ratio of Rwe AG Neu Essen (PK)?

The cash to sales ratio of Rwe AG Neu Essen (PK) is 2.35

What is the registered address of Rwe AG Neu Essen (PK)?

The registered address for Rwe AG Neu Essen (PK) is RWE Platz 1, Essen, North Rhine-Westphalia, 45141

What is the Rwe AG Neu Essen (PK) website address?

The website address for Rwe AG Neu Essen (PK) is www.rwe.com

Which industry sector does Rwe AG Neu Essen (PK) operate in?

Rwe AG Neu Essen (PK) operates in the Regulated Utilities sector

scotty3371

scotty3371 5分前

You would think at least shareholders would be able to watch live!!

Thomas@yahoo

Thomas@yahoo 8分前

Breaking CBD News:

💥 https://www.mdpi.com/2076-3921/15/6/754

💥 https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2026.1794084/full

💥 https://journals.sagepub.com/doi/10.1177/25785125261458680

Mojocash

Mojocash 13分前

Best time to buy is now. They will announce the end of the current convertible soon. .0001

floblu14

floblu14 14分前

Form 424B5 - Prospectus [Rule 424(b)(5)]
July 02 2026 - 4:54PM

https://investorshub.advfn.com/stock-market/NASDAQ/enanta-pharmaceuticals-ENTA/stock-news/98860515/form-424b5-prospectus-rule-424b5

JoeForkeyBolo

JoeForkeyBolo 18分前

Zero, yes I have modified my drawdown strategy a bit. There's nothing wrong with starting it after 2 consecutive buys, but I tested letting buys continue with no Buy SAFE adjustments until the average drawdown had been achieved. This adds a bit of an additional layer to the strategy, and I had to mo

ausbak51

ausbak51 22分前

I thought Tim Pagliara was back on X. Been holding JPS for a bit. I guess it was someone else. Where did he go?
https://x.com/nicosintichakis/status/2072932687266943155?s=20

DocLee

DocLee 30分前

Today's the day and the hour is 11.13am BST (= 10.10am GMT) so Dr Bosch should be well into his stride.BETHESDA, Md., July 2, 2026 -- Northwest Biotherapeutics (OTCQB:NWBO) (the “Company” or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancer

eagle8

eagle8 34分前

RIP_GOP
@RIP_GOP1234
$NWBO #DCVAX 😎👇🏽

https://prnewswire.com/news-releases/high-grade-glioma-market-witnesses-strong-momentum-during-the-forecast-period-20262036-with-increasing-clinical-activity-and-drug-development--delveinsight-302815434.html

eagle8

eagle8 37分前

Justin Keister MS DABR
@justinkeister5
Irrefutable evidence of the successes of personalized dendritic cell vaccination? This would be the forum to tell surgeons how to keep GBM patients alive longer and, in some cases, potentially cure this disease.

$NWBO
Quote

shajandr

shajandr 38分前

HGENQ has no management; it only has a bankruptcy trustee/receiver for liquidation.

There are no officers and no directors. Humanigen is inliquidation bankruptcy. Further, in corporate liquidation bankruptcies, debts are nott discharged, the unpaid debts remain forever - ergo the corp

floblu14

floblu14 39分前

Additional info re: Dew's post -

Enanta Pharmaceuticals intends to offer and sell up to $75,000,000 of its common stock through an Open Market Sale (sales agreement) with Jefferies LLC as sales agent under an at-the-market offering structure. The sales agreement permits sales from tim

gregcod

gregcod 46分前

Hi Trader maybe if you would post that report and paste it to here for investors to see.dont want to keep this quiet..or maybe i should stay quiet?? the link is again,
AInvest.com/news/ibat-Q4update..US Mag..all things concidered..All things possible.

iHub News

iHub News 1時間前

U.S. holiday pause, softer Fed expectations and Asia rebound shape global markets: Dow Jones, S&P, Nasdaq, Wall Street FuturesJuly 3, 2026 5:19 AM
IH Market News

iHub News

iHub News 1時間前

Tesla’s strong Q2 deliveries lift Chinese supplier sharesJuly 3, 2026 5:21 AM
IH Market News Tesla (NASDAQ:TS

Ace Trader

Ace Trader 1時間前

I wonder if they are fishing for evidence for an appeal to SCOTUS if they lose this verdict coming this month.? What's the bottom line for sending in Pulte to dig up dirt ??? The 11,000 docs ? or more mortgage fraud ??

jxyzobrien

jxyzobrien 1時間前

sector rotation
https://www.youtube.com/watch?v=7G9qvhO7AR8

Dram caused NDX selling friday

NDX
https://stockcharts.com/sc3/ui/?s=%24NDX&a=2094034028

Ace Trader

Ace Trader 1時間前

Agreed !
They have changed their tune from release to maybe to No rush. So what's it going to be next month? I think they are either building a master plan for the SWF or its a release as DJT walks out the door and a big win for all that donated and his buddies. This will be a big win for sha

eagle8

eagle8 1時間前

flipper,
could it be that those 10-year survival rates from DCvax, which you've talked about a lot, are also going to be included in this ( Dr. Bosch) presentation?
That would be something, because (whatever external placebo) the placebo over 10 years is at or near 0%.
It could

Mrs kronwell

Mrs kronwell 1時間前

We’ll likely be able to infer more if the replacement the coo position. So either. 1. The President hiring will be mostly offset with coo cost reductions or 2. There was a difference in opinion on direction or execution with the person in that position.

superman2026

superman2026 1時間前

Largest shareholder by gifting herself huge shares.

gregcod

gregcod 1時間前

If someone here on this board can go tto that report od AInvest.com/news/ibat.q4-update and copy it and post that report here ..Maybe I should be quiet..but I must ask for the board to post that report here..I dont know how to copy it.im an idiot but someone here can do it!.Its a great report before

t1215s

t1215s 2時間前

Jhd I have a few min.i will reply now “ I believe the 16’s are a lock today (16.09)and then some ,as of this post (8:41AM.) , And that we might hold for the close also AIMHO according to the pre #s”( check the pre numbers on the chart——————->>>>>

I have been told something about alph

gregcod

gregcod 2時間前

Go to AInvest.com/news/ibat.q4update to read report of US Mag continuing their relationship w IBAT..Utah..The price of ithium could be the reasoning LONG WITH THE UPDATES SINCE THAT FIRST PLANT CONTRACT OCCURED 2 YEARS AGO..DONT THINK IM NUTS..READ THE REPORT! AND HIT THE LIKE BUTTON..loli I thou

Rwe AG Neu Essen (PK)

Amundi CAC 40 UCITS ETF

Laboratorio Farmaceutico...

Golden Lake Exploration ()

iShares VII (PK)

BetaShares Capital

Onward Medical NV (QX)

EN CDP W EZ EW NR

Power Group Projects

Orion Corporation A

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。